Antibiotic prophylaxis in cerebrospinal fluid shunting: Reassessment of Cefotiam penetration into human CSF

Zentralblatt fur Neurochirurgie

Volumn 68, Issue 1, 2007, Pages 14-18

  Knoop, M ^a   Schutze M ^b   Piek, J ^b   Drewelow, B ^b   Mundkowski, R ^b  

^a HELIOS Klinikum Bad Saarow   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Antibiotic prophylaxis; Blood brain barrier; Cefotiam penetration; Cerebrospinal fluid; Shunting

Indexed keywords

BETA LACTAM; CEFOTIAM;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOASSAY; BLOOD BRAIN BARRIER; BRAIN ARTERY ANEURYSM; BRAIN TUMOR; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FISTULA; CEREBROSPINAL FLUID SHUNTING; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MALE; NEUROSURGERY; SHUNT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD-BRAIN BARRIER; CEFOTIAM; CEREBROSPINAL FLUID SHUNTS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; SARCINA;

EID: 34248184019     PISSN: 00444251     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-968168     Document Type: Article

References (33)

1. Arnaboldi L: Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures. A prospective study of 100 patients undergoing shunt operations. Chemotherapy 1996; 42: 384-390
2. Bayston R: Hydrocephalus shunt infections. Journal of Antimicrobial Chemotherapy 1994; 34 (Suppl A): 75-84
3. Bodey G, Fainstein V, Hinkle AM: Comparative in vitro study of new cephalosporins. Antimicrob Agents Chemother 1981; 20 (2):226-230
4. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE: Risk of infection after cerebrospinal fluid shunt: An analysis of 884 first-time shunts. Acta Neurochir 1995; 136: 1-7
5. Brogard JM, Jehl F, Willemin B, Lamalle AM, Blickle JF, Monteil H: Clinical pharmacokinetics of Cefotiam. Clin Pharmacokinet 1989; 17: 163-174
6. Daschner FD, Hemmer KA, Offermann P, Slanicka J: Pharmacokinetics of Cefotiam in normal humans. Antimicrob Agents Chemother 1982; 22: 958-960
7. Eguchi T, Mayanagi Y, Hanamura T, Iai S, Asai A: The migration of Cefotiam to cerebrospinal fluid [in Japanese]. Jpn J Antibiot 1983; 36 (2): 213-220
8. Gaillard T, Gilsbach JM: Intra-operative antibiotic prophylaxis in neurosurgery. A prospective, randomized, controlled study on Cefotiam. Acta Neurochir 1991; 113: 103-109
9. Garzone P, Lyon J, Yu VL: Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries. Drug Intell Clin Pharm 1983; 17 (9): 615-622
10. George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 1979; 51: 804-881
11. Hoellman DB, Spangler SK, Jacobs MR, Appelbaum PC: In vitro activities of Cefminox against anaerobic bacteria compared with those of nine other compounds. Antimicrob Agents Chemother 1998; 42 (3): 495-501
12. Holloway KL, Smith KW, Wilberger JE, Jemsek JG, Giguere GC, Collins JJ: Antibiotic prophylaxis during clean neurosurgery: A large, multicenter study using cefuroxime. Clinical Therapeut 1996; 18: 84-94
13. Imagawa K, Kawasaki M, Toda I, Hayashi M, Asai A, Nomura T: A study on penetration of antibiotics into the cerebrospinal fluid after ventriculo-peritoneal shunt [in Japanese]. Jpn J Antibiot 1982; 35 (4): 1072-1079
14. Imagawa K, Nomura T, Asai A, Hayashi M, Toda I, Kawasaki M: Prophylactic administration of an antibiotic in neurosurgical operations - penetration of Cefotiam into cerebrospinal fluid [in Japanese]. Jpn J Antibiot 1983; 36 (12): 3422-3428
15. Ito H, Uno E, Tsuji T, Sato K, Yamamoto S: Concentration of Cefotiam in cerebrospinal fluid [in Japanese]. Jpn J Antibiot 1982; 35 (5): 1183-1186
16. Kodama Y, Sakata K, Fujiwara M, Kitsugi T: Study on penetration of Cefotiam into cerebrospinal fluid [in Japanese]. Jpn J Antibiot 1984; 37 (10): 1757-1762
17. Kojima T, Waga S, Morikawa A, Okada M, Furuno M, Shimizu T: Penetration of Cefotiam dihydrochloride into cerebrospinal fluid [in Japanese]. Jpn J Antibiot 1982; 35 (4): 1063-1067
18. Konishi K, Ozawa Y: Pharmacokinetics of Cefotiam in patients with impaired renal function and in those undergoing hemodialysis. Antimicrob Agents Chemother 1984; 26: 647-651
19. Kropec A, Daschner F: In vitro activity of fleroxacin and 14 other antimicrobials against slime- and non-slime-producing Staphylococcus epidermidis. Chemotherapy 1989; 35: 351-354
20. Kubota M, Sakai T, Mizutani H: Clinical evaluation of Cefotiam in the cerebrospinal fluid of patients with ruptured cerebral aneurysms in the acute stage [in Japanese]. Jpn J Antibiot 1985; 38 (8):2139-2144
21. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001; 94: 195-201
22. Lutsar I, McCracken GH, Friedland IR: Antibiotic pharmacodynamics in cerebrospinal fluid. Clinical Infectious Diseases 1998; 27: 1117-1129
23. Maier W, Strutz J: Concentrations of cephalosporins in tissues of the head and neck after parenteral infusion. Chemotherapy 1995; 41 (6): 421-426
24. Matsumoto M, Tamaoka H, Ishikawa H, Kikuchi M: In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic. Antimicrob Agents Chemother 1998; 42 (11): 2943-2949
25. Meier H, Zerfowski M, Schlegel P: Excretion of beta-lactam antibiotics in human parotid [in German]. HNO 1991; 39 (3): 102-107
26. Nakashio S, Nakamura M: In vitro activity of cefotaxime against clinically significant pathogens. Drugs 1988; 35 (Suppl. 2): 14-21
27. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF: Factors causing acute shunt infection. J Neurosurg 1984; 61: 1072-1078
28. Ronan A, Hogg GG, Klug GL: Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995; 14: 782-786
29. Rouan MC, Lecaillon JB, Guibert J, Modai J, Schoeller JP: Pharmacokinetics of Cefotiam in humans. Antimicrob Agents Chemother 1985; 27: 177-180
30. Spanu G, Karussos G, Adinolfi D, Bonfanti N: An analysis of cerebrospinal fluid shunt infections in adults. A clinical experience of twelve years. Acta Neurochir 1986; 80: 79-82
31. Watanabe NA, Katsu K, Moriyama M, Kitoh K: In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity. Antimicrob Agents Chemother 1988; 32 (5): 693-701
32. Yoshihara T, Kitaoka T, Tomihara K, Nomura M, Uozumi T: Cerebrospinal fluid transfer of Cefotiam (CTM). Its relationship to CT [in Japanese]. No Shinkei Geka 1985; 13 (9): 965-971
33. Zentner J, Gilsbach J, Felder T: Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients. Neurosurg Rev 1995; 18: 169-172